Evaluation of cognitive deficits and structural hippocampal damage in encephalitis with leucine-rich, glioma-inactivated 1 antibodies

JAMA Neurology

Volumn 74, Issue 1, 2017, Pages 50-59

  Finke, Carsten ^a,b   Prüss, Harald ^a,c   Heine, Josephine ^a   Reuter, Sigrid ^a,d   Kopp, Ute A ^a   Wegner, Florianmd ^e   Bergh, Florian Then ^f   Koch, Sebastian ^d   Jansen, Olav ^d   Münte, Thomas ^g   Deuschl, Günther ^d   Ruprecht, Klemens ^a   Stöcker, Winfried ^h   Klaus Peterwandinger, K P ^g   Paul, Friedemann ^a,i   Bartsch, Thorsten ^d  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b HUMBOLDT UNIVERSITY   (Germany)

^c GERMAN CENTER FOR NEURODEGENERATIVE DISEASES DZNE   (Germany)

^d UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

^e HANNOVER MEDICAL SCHOOL   (Germany)

^f UNIVERSITY OF LEIPZIG   (Germany)

^g UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

^h Institute of Experimental Immunology   (Germany)

ⁱ MAX DELBRÜCK CENTER FOR MOLECULAR MEDICINE   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICONVULSIVE AGENT; AUTOANTIBODY; AZATHIOPRINE; CORTICOSTEROID; CYCLOPHOSPHAMIDE; IMMUNOGLOBULIN; LEUCINE RICH GLIOMA INACTIVATED 1 ANTIBODY; METHOTREXATE; RITUXIMAB; UNCLASSIFIED DRUG; LGI1 PROTEIN, HUMAN; PROTEIN;

AGED; ALLERGIC ENCEPHALITIS; ARTICLE; BASAL GANGLION; BRAIN ATROPHY; BRAIN DAMAGE; BRAIN SIZE; CLINICAL ARTICLE; COGNITIVE DEFECT; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DENTATE GYRUS; DENTATE HILUS; DEPTH PERCEPTION; DISEASE SEVERITY; FEMALE; GERMANY; GLOBUS PALLIDUS; GRAY MATTER; HIPPOCAMPAL CA2 REGION; HIPPOCAMPAL CA3 REGION; HIPPOCAMPUS; HUMAN; IMMUNOTHERAPY; LEFT HEMISPHERE; LEUCINE RICH GLIOMA INACTIVATED 1 ANTIBODY ASSOCIATED ENCEPHALITIS; MALE; MEMORY DISORDER; NUCLEAR MAGNETIC RESONANCE IMAGING; PLASMA EXCHANGE; SEIZURE; VERBAL MEMORY; WHITE MATTER; BLOOD; CLINICAL TRIAL; COGNITION DISORDERS; COMPLICATION; DIAGNOSTIC IMAGING; DISABILITY; HEK293 CELL LINE; IMMUNOLOGY; LIMBIC ENCEPHALITIS; LONGITUDINAL STUDY; METABOLISM; MIDDLE AGED; MULTICENTER STUDY; NEUROPSYCHOLOGICAL TEST; RETROSPECTIVE STUDY;

AGED; AUTOANTIBODIES; BASAL GANGLIA; COGNITION DISORDERS; CROSS-SECTIONAL STUDIES; DISABILITY EVALUATION; FEMALE; HEK293 CELLS; HIPPOCAMPUS; HUMANS; IMMUNOTHERAPY; LIMBIC ENCEPHALITIS; LONGITUDINAL STUDIES; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; NEUROPSYCHOLOGICAL TESTS; PROTEINS; RETROSPECTIVE STUDIES;

EID: 85011422721     PISSN: 21686149     EISSN: None     Source Type: Journal    
DOI: 10.1001/jamaneurol.2016.4226     Document Type: Article

References (50)

1. Irani SR, Alexander S,Waters P, et al. Antibodies to Kv1 potassium channel-complex proteins leucine-rich, glioma inactivated 1 protein and contactin-associated protein-2 in limbic encephalitis, Morvan's syndrome and acquired neuromyotonia. Brain. 2010;133(9):2734-2748.
2. Lai M, Huijbers MGM, Lancaster E, et al. Investigation of LGI1 as the antigen in limbic encephalitis previously attributed to potassium channels: a case series. Lancet Neurol. 2010;9(8): 776-785.
3. Irani SR, Michell AW, Lang B, et al. Faciobrachial dystonic seizures precede LgI1 antibody limbic encephalitis. Ann Neurol. 2011;69(5):892-900.
4. Irani SR, Stagg CJ, Schott JM, et al. Faciobrachial dystonic seizures: the influence of immunotherapy on seizure control and prevention of cognitive impairment in a broadening phenotype. Brain. 2013;136(pt 10):3151-3162.
5. Shin Y-W, Lee S-T, Shin J-W, et al. VGKC-complex/LGI1-antibody encephalitis: clinical manifestations and response to immunotherapy. J Neuroimmunol. 2013;265(1-2):75-81.
6. Heine J, Prüss H, Bartsch T, Ploner CJ, Paul F, Finke C. Imaging of autoimmune encephalitis- relevance for clinical practice and hippocampal function. Neuroscience. 2015;309:68-83.
7. Finke C, Kopp UA, Pajkert A, et al. Structural hippocampal damage following anti-N-methyl-D-aspartate receptor encephalitis. Biol Psychiatry. 2016;79(9):727-734.
8. Finke C, Kopp UA, Scheel M, et al. Functional and structural brain changes in anti-N-methyl-D-aspartate receptor encephalitis. Ann Neurol. 2013;74(2):284-296.
9. Plantone D, Renna R, Grossi D, Plantone F, Iorio R. Basal ganglia involvement in facio-brachial dystonic seizures associated with LGI1 antibodies. Neurology. 2013;80(17):e183-e184.
10. Boesebeck F, Schwarz O, Dohmen B, et al. Faciobrachial dystonic seizures arise from cortico-subcortical abnormal brain areas. J Neurol. 2013;260(6):1684-1686.
11. Flanagan EP, Kotsenas AL, Britton JW, et al. Basal ganglia T1 hyperintensity in LGI1-autoantibody faciobrachial dystonic seizures. Neurol Neuroimmunol Neuroinflamm. 2015;2(6):e161.
12. Fidzinski P, Jarius S, Gaebler C, Boegner F, Nohr R, Ruprecht K. Faciobrachial dystonic seizures and antibodies to Lgi1 in a 92-year-old patient: a case report. J Neurol Sci. 2014;347(1-2):404-405.
13. Wegner F, Wilke F, Raab P, et al. Anti-leucine rich glioma inactivated 1 protein and anti-N-methyl-D-aspartate receptor encephalitis show distinct patterns of brain glucose metabolism in 18F-fluoro-2-deoxy-d-glucose positron emission tomography. BMC Neurol. 2014;14(1):136.
14. Rankin J. Cerebral vascular accidents in patients over the age of 60, II: prognosis. Scot Med J. 1957;2 (5):200.
15. Helmstaedter C, Lendt M, Lux S. Verbaler Lern-und Merkfähigkeitstest (VLMT). Göttingen, Germany: Hogrefe; 2001.
16. Stern RA, Javorsky DJ, Singer EA, et al. BQSS: the Boston Qualitative Scoring System for the Rey Osterrieth Complex Figure. Odessa, FL: Psychological Assessment Resources Inc; 1999.
17. Zimmermann P, Fimm B. Testbatterie zur Aufmerksamkeitsprüfung (TAP)-Test of Attentional Performance. Version. 2. 3rd ed. Herzogenrath, Germany: Psytest; 2012.
18. Aschenbrenner S, Tucha O, Lange KW. RegensburgWord Fluency Test (Regensburger Wortflüssigkeits-Test [RWT)]. Göttingen, Germany: Hogrefe; 2000.
19. Lehrl S. Mehrfachwahl-Wortschatz-Intelligenz-Test,MWT-B. 5th ed. Balingen, Germany: Spitta Verlag; 2005.
20. HornW. L-P-S Leistungsprüfsystem. 2nd ed. Göttingen, Germany: Hogrefe; 1983.
21. Morey RA, Petty CM, Xu Y, et al. A comparison of automated segmentation and manual tracing for quantifying hippocampal and amygdala volumes. Neuroimage. 2009;45(3):855-866.
22. Van Leemput K, Bakkour A, Benner T, et al. Automated segmentation of hippocampal subfields from ultra-high resolution in vivo MRI. Hippocampus. 2009;19(6):549-557.
23. Fisher RS, Cross JH, French JA, et al. Operational classification of seizure types by the International League Against Epilepsy. http://www .ilae.org/visitors/centre/documents/ClassificationSeizureILAE-2016.pdf. Published 2016. Accessed October 19, 2016.
24. BlumeWT, Lüders HO, Mizrahi E, Tassinari C, van Emde BoasW, Engel J Jr. Glossary of descriptive terminology for ictal semiology: report of the ILAE Task Force on Classification and Terminology. Epilepsia. 2001;42(9):1212-1218.
25. Malter MP, Frisch C, Schoene-Bake JC, et al. Outcome of limbic encephalitis with VGKC-complex antibodies: relation to antigenic specificity. J Neurol. 2014;261(9):1695-1705.
26. Klein CJ, Lennon VA, Aston PA, et al. Insights from LGI1 and CASPR2 potassium channel complex autoantibody subtyping. JAMA Neurol. 2013;70 (2):229-234.
27. Toledano M, Britton JW, McKeon A, et al. Utility of an immunotherapy trial in evaluating patients with presumed autoimmune epilepsy. Neurology. 2014;82(18):1578-1586.
28. Irani SR, Gelfand JM, Bettcher BM, Singhal NS, Geschwind MD. Effect of rituximab in patients with leucine-rich, glioma-inactivated 1 antibody-associated encephalopathy. JAMA Neurol. 2014;71(7):896-900.
29. Finke C, Kopp UA, Prüss H, Dalmau J, Wandinger K-P, Ploner CJ. Cognitive deficits following anti-NMDA receptor encephalitis. J Neurol Neurosurg Psychiatry. 2012;83(2):195-198.
30. Flanagan EP, McKeon A, Lennon VA, et al. Autoimmune dementia: clinical course and predictors of immunotherapy response. Mayo Clin Proc. 2010;85(10):881-897.
31. Quek AML, Britton JW, McKeon A, et al. Autoimmune epilepsy: clinical characteristics and response to immunotherapy. Arch Neurol. 2012;69 (5):582-593.
32. Wieser S, Kelemen A, Barsi P, et al. Pilomotor seizures and status in non-paraneoplastic limbic encephalitis. Epileptic Disord. 2005;7(3):205-211.
33. Rocamora R, Becerra JL, Fossas P, et al. Pilomotor seizures: an autonomic semiology of limbic encephalitis? Seizure. 2014;23(8):670-673.
34. Symvoulakis EK, Anyfantakis D, Zaganas I. Pilomotor seizures: an unusual presentation of limbic encephalitis. Acta Neurol Belg. 2016;116(3): 365-367.
35. Bartsch T,Wulff P. The hippocampus in aging and disease: from plasticity to vulnerability. Neuroscience. 2015;309(8):1-16.
36. Bartsch T, Döhring J, Reuter S, et al. Selective neuronal vulnerability of human hippocampal CA1 neurons: lesion evolution, temporal course, and pattern of hippocampal damage in diffusion-weighted MR imaging. J Cereb Blood Flow Metab. 2015;35(11):1836-1845.
37. Kotsenas AL,Watson RE, Pittock SJ, et al. MRI findings in autoimmune voltage-gated potassium channel complex encephalitis with seizures: one potential etiology for mesial temporal sclerosis. AJNR Am J Neuroradiol. 2014;35(1):84-89.
38. Bien CG, Urbach H, Schramm J, et al. Limbic encephalitis as a precipitating event in adult-onset temporal lobe epilepsy. Neurology. 2007;69(12): 1236-1244.
39. Wagner J, Witt JA, Helmstaedter C, Malter MP, Weber B, Elger CE. Automated volumetry of the mesiotemporal structures in antibody-associated limbic encephalitis. J Neurol Neurosurg Psychiatry. 2015;86(7):735-742.
40. Bartsch T, Schönfeld R, Müller FJ, et al. Focal lesions of human hippocampal CA1 neurons in transient global amnesia impair place memory. Science. 2010;328(5984):1412-1415.
41. Herranz-Pérez V, Olucha-Bordonau FE, Morante-Redolat JM, Pérez-Tur J. Regional distribution of the leucine-rich glioma inactivated (LGI) gene family transcripts in the adult mouse brain. Brain Res. 2010;1307:177-194.
42. Zeineh MM, Engel SA, Thompson PM, Bookheimer SY. Dynamics of the hippocampus during encoding and retrieval of face-name pairs. Science. 2003;299(5606):577-580.
43. Suthana N, Ekstrom A, Moshirvaziri S, Knowlton B, Bookheimer S. Dissociations within human hippocampal subregions during encoding and retrieval of spatial information. Hippocampus. 2011;21(7):694-701.
44. Bakker A, Kirwan CB, Miller M, Stark CEL. Pattern separation in the human hippocampal CA3 and dentate gyrus. Science. 2008;319(5870):1640-1642.
45. Bonnici HM, Chadwick MJ,Maguire EA. Representations of recent and remote autobiographical memories in hippocampal subfields. Hippocampus. 2013;23(10):849-854.
46. Le Bihan D, Mangin JF, Poupon C, et al. Diffusion tensor imaging: concepts and applications. J Magn Reson Imaging. 2001;13(4): 534-546.
47. Carlesimo GA, Cherubini A, Caltagirone C, Spalletta G. Hippocampal mean diffusivity and memory in healthy elderly individuals: a cross-sectional study. Neurology. 2010;74(3):194-200.
48. den Heijer T, der Lijn Fv, VernooijMW, et al. Structural and diffusion MRI measures of the hippocampus and memory performance. Neuroimage. 2012;63(4):1782-1789.
49. Demey I, Ventrice F, Rojas G, Allegri R, Zubiri V, Somale V. Hippocampal mean diffusivity is a biomarker of neuronal injury in patients with mild cognitive impairment and Alzheimer's disease dementia [abstract]. Neurology. 2015;84(14) (suppl):P6.212.
50. Navarro V, Kas A, Apartis E, et al. Motor cortex and hippocampus are the two main cortical targets in LGI1-antibody encephalitis. Brain. 2016;139(pt 4): 1079-1093.